{
    "clinical_study": {
        "@rank": "24943", 
        "acronym": "BRAIN-HF", 
        "arm_group": [
            {
                "arm_group_label": "Controls", 
                "description": "Age matched healthy subjects"
            }, 
            {
                "arm_group_label": "Mild DCM", 
                "description": "Heart failure patients with dilated cardiomyopathy (DCM) with NYHA-functional class II"
            }, 
            {
                "arm_group_label": "Severe DCM", 
                "description": "Heart failure patients with dilated cardiomyopathy (DCM) with NYHA-functional class III/IV"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators will evaluate the determinants of cerebral impairment in patients with\n      non-ischemic heart failure compared to controls, and its relation to cognitive function.\n      They hypothesize that patients with heart failure have impaired brain perfusion and\n      hemodynamic factors are associated with cognitive dysfunction."
        }, 
        "brief_title": "Brain Function and Perfusion in Patients With Heart Failure", 
        "condition": [
            "Heart Failure", 
            "Dilated Cardiomyopathy", 
            "Perfusion", 
            "Cognitive Impairment", 
            "Cerebral Hypoperfusion"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiomyopathy, Dilated", 
                "Heart Failure", 
                "Cognition Disorders", 
                "Cardiomyopathies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria Control Group:\n\n          -  Healthy subject, as assessed by clinician\n\n          -  Age matched with patient group\n\n        Exclusion Criteria Control Group:\n\n          -  Age < 18 years\n\n          -  Carotid artery or intracranial disease, as assessed by echo-doppler (significant\n             stenosis > 50%)\n\n          -  Unable or unwilling to undergo MRI\n\n          -  The presence of ferromagnetic material in or on the body, for example tattoos with\n             ferrous ink or pacemakers or cardiac defibrillators. Also the presence of pregnancy\n             and claustrophobia.\n\n          -  History of cognitive impairment\n\n          -  Unable to understand procedures\n\n          -  Unable or unwilling to provide informed consent\n\n        Inclusion Criteria DCM-group:\n\n          -  Heart failure due to DCM\n\n          -  15 patients with NYHA class II\n\n          -  15 patients with NYHA class III/IV\n\n        Exclusion Criteria DCM-Group:\n\n          -  Age < 18 years\n\n          -  History of myocardial infarction\n\n          -  History of peripheral artery disease\n\n          -  History of cerebrovascular disease or\n\n          -  Carotid artery or intracranial disease, as assessed by echo-doppler (significant\n             stenosis > 50%)\n\n          -  History of cognitive impairment\n\n          -  Unable to undergo MRI (eg pacemaker)\n\n          -  Unable to understand procedures\n\n          -  Unable or unwilling to provide informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "-  Patients with heart failure due to dilated cardiomyopathy with NYHA II or NYHA II/IV.\n\n          -  Healthy patients"
            }
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01756014", 
            "org_study_id": "BRAIN-HF"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 21, 2012", 
        "location": {
            "contact": {
                "email": "a.a.voors@umcg.nl", 
                "last_name": "Adriaan A Voors, MD/PhD", 
                "phone": "+31 50 36 12355"
            }, 
            "facility": {
                "address": {
                    "city": "Groningen", 
                    "country": "Netherlands", 
                    "zip": "9700 RB"
                }, 
                "name": "University Medical Centre Groningen"
            }, 
            "investigator": [
                {
                    "last_name": "Adriaan A Voors, MD/PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Gert-Jan Luijckx, MD/PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Vincent M van Deursen, MD/PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "3", 
        "official_title": "Brain Function and Perfusion in Patients With Heart Failure", 
        "overall_contact": {
            "email": "a.a.voors@umcg.nl", 
            "last_name": "Adriaan A Voors, MD/PhD", 
            "phone": "+31 50 3612355"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Determinants of cerebral impairment in patients with heart failure compared to controls, where cerebral impairment is defined as decreased cognitive function and cerebral hypoperfusion", 
            "measure": "Determinants of cerebral impairment", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01756014"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Medical Centre Groningen", 
            "investigator_full_name": "A.A.Voors", 
            "investigator_title": "Prof. dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Prevalence of cognitive impairment in patients with heart failure", 
                "measure": "Prevalence of cognitive impairment", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Relation of cognitive impairment with perfusion of carotid artery territory and basilar artery territory", 
                "measure": "Relation of cognitive impairment with local perfusion", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Relation of cognitive impairment with the severity of heart failure", 
                "measure": "Relation of cognitive impairment with the severity of heart failure", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Relation of cognitive impairment with cardiac output", 
                "measure": "Relation of cognitive impairment with cardiac output", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Relation of cognitive impairment with the severity of congestion", 
                "measure": "Relation of cognitive impairment with the severity of congestion", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Relation of cognitive impairment with the decrease in cerebral perfusion", 
                "measure": "Relation of cognitive impairment with the decrease in cerebral perfusion", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "The difference of cognitive domains in above relations", 
                "measure": "The difference of cognitive domains in above relations", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }
        ], 
        "source": "University Medical Centre Groningen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Medical Centre Groningen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}